CannaNovaFilm
CannaNova LLC Announces its Formation; CannaNova will Commercialize Consumer Cannabinoid Consumables Using DepoFilm™ Oral Film Technology
19 juil. 2022 08h00 HE | CannaNova LLC
Greensboro, NC, July 19, 2022 (GLOBE NEWSWIRE) -- CannaNova Cannabinoid Film CannaNova LLC today announced its formation to pursue the consumer cannabinoid space, employing DepoFilm™...
IGX Bigger Size Logo.jpg
IntelGenx Announces Addition of Peterborough’s Kawartha Centre as Montelukast VersaFilm® Phase 2a Clinical Trial Site
19 juin 2019 08h00 HE | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, June 19, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that, the Kawartha Centre has...
IGX Bigger Size Logo.jpg
IntelGenx Announces Addition of Ottawa Montelukast VersaFilm® Phase 2a Clinical Trial Site; First Patient in Study Completes 26-Week Treatment
10 juin 2019 08h00 HE | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, June 10, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), leader in pharmaceutical films, today announced that it has added a new Ottawa site...
IGX Bigger Size Logo.jpg
IntelGenx Reports First Quarter 2019 Financial Results
09 mai 2019 16h00 HE | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, May 09, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") today reported financial results for the first quarter...
IGX Logo Medium Size.jpg
IntelGenx Announces the Appointment of André Godin as President and Chief Financial Officer
08 mai 2019 16h15 HE | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, May 08, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that its Board of...
IGX Logo Medium Size.jpg
IntelGenx and Aquestive Therapeutics Enter Worldwide Collaboration Agreement for Tadalafil
08 mai 2019 07h00 HE | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, May 08, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it has entered into a...
IGX Logo Medium Size.jpg
IntelGenx to Report First Quarter 2019 Financial Results on May 9, 2019 – Conference Call to Follow
02 mai 2019 08h00 HE | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, May 02, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) today announced that it will release its first quarter 2019 financial results...
IGX Logo Medium Size.jpg
IntelGenx Announces Issuance of Second U.S. Patent for Topical Oral Film Technology
01 mai 2019 08h00 HE | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, May 01, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that the United States Patent...
IGX Logo Medium Size.jpg
IntelGenx to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference
25 avr. 2019 08h00 HE | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, April 25, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that its Executive...
IGX Logo Medium Size.jpg
IntelGenx to Promote VetaFilm™ Oral Film Technology at Human Biotech & Animal Health Business Partnering Summit
08 avr. 2019 08h00 HE | IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, April 08, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it will promote its...